Profitability Metrics

Gross Margin
100.00%
Operating Margin
13.91%
Net Margin
18.47%

Efficiency Metrics

Revenue per Expense Ratio
1.00
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
14.66%
Income Tax Rate
-32.81%
EPS
$0.00

Balance Sheet Analysis

Current Ratio
8.48
Cash Ratio
3.71
Working Capital
$10.60B
Debt to Equity
0.13
Debt to Assets
2.54%
Equity Ratio
19.10%

Cash Flow Analysis

Operating Cash Flow Ratio
11.22%
Free Cash Flow Ratio
10.91%
CapEx to Revenue
0.31%
Dividends Paid
$90.20M
Stock Buybacks
No buybacks
Total Shareholder Returns
$90.20M
Cash Position Change
7.18%

Key Takeaways (2023 FY)

  • Maintained positive net income growth despite revenue changes

Detailed Growth Metrics

Core Performance

Revenue
9.86%
Net Income
946.38%
EPS
0.00%
Operating Income
1,197.00%

Operational Efficiency

R&D Expenses
0.00%
SG&A Expenses
30.30%
Operating Cash Flow
690.36%
Free Cash Flow
674.18%

Balance Sheet Health

Assets
0.45%
Debt
28.74%
Book Value per Share
0.00%
Inventory
0.00%

Shareholder Returns

Dividends per Share
0.00%
Shares Outstanding
0.00%

Long Term Trends

3Y Revenue/Share
0.00%
5Y Revenue/Share
-100.00%
3Y Dividend/Share
0.00%
5Y Dividend/Share
0.00%